Literature DB >> 22158966

TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Marta Montes1, Alexandre Cloutier, Noemí Sánchez-Hernández, Laetitia Michelle, Bruno Lemieux, Marco Blanchette, Cristina Hernández-Munain, Benoit Chabot, Carlos Suñé.   

Abstract

Complex functional coupling exists between transcriptional elongation and pre-mRNA alternative splicing. Pausing sites and changes in the rate of transcription by RNA polymerase II (RNAPII) may therefore have fundamental impacts in the regulation of alternative splicing. Here, we show that the elongation and splicing-related factor TCERG1 regulates alternative splicing of the apoptosis gene Bcl-x in a promoter-dependent manner. TCERG1 promotes the splicing of the short isoform of Bcl-x (Bcl-x(s)) through the SB1 regulatory element located in the first half of exon 2. Consistent with these results, we show that TCERG1 associates with the Bcl-x pre-mRNA. A transcription profile analysis revealed that the RNA sequences required for the effect of TCERG1 on Bcl-x alternative splicing coincide with a putative polymerase pause site. Furthermore, TCERG1 modifies the impact of a slow polymerase on Bcl-x alternative splicing. In support of a role for an elongation mechanism in the transcriptional control of Bcl-x alternative splicing, we found that TCERG1 modifies the amount of pre-mRNAs generated at distal regions of the endogenous Bcl-x. Most importantly, TCERG1 affects the rate of RNAPII transcription of endogenous human Bcl-x. We propose that TCERG1 modulates the elongation rate of RNAPII to relieve pausing, thereby activating the proapoptotic Bcl-x(S) 5' splice site.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158966      PMCID: PMC3272968          DOI: 10.1128/MCB.06255-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  71 in total

1.  Promoter proximal splice sites enhance transcription.

Authors:  Andre Furger; Justin M O'Sullivan; Alexandra Binnie; Barbara A Lee; Nick J Proudfoot
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

2.  Perturbation of transcription elongation influences the fidelity of internal exon inclusion in Saccharomyces cerevisiae.

Authors:  Kenneth James Howe; Caroline M Kane; Manuel Ares
Journal:  RNA       Date:  2003-08       Impact factor: 4.942

3.  A slow RNA polymerase II affects alternative splicing in vivo.

Authors:  Manuel de la Mata; Claudio R Alonso; Sebastián Kadener; Juan P Fededa; Matías Blaustein; Federico Pelisch; Paula Cramer; David Bentley; Alberto R Kornblihtt
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

4.  The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.

Authors:  Kai-Ti Lin; Ruei-Min Lu; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

5.  FF domains of CA150 bind transcription and splicing factors through multiple weak interactions.

Authors:  Matthew J Smith; Sarang Kulkarni; Tony Pawson
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome.

Authors:  Evgeny M Makarov; Olga V Makarova; Henning Urlaub; Marc Gentzel; Cindy L Will; Matthias Wilm; Reinhard Lührmann
Journal:  Science       Date:  2002-10-31       Impact factor: 47.728

7.  Transcriptional activators differ in their abilities to control alternative splicing.

Authors:  Guadalupe Nogues; Sebastian Kadener; Paula Cramer; David Bentley; Alberto R Kornblihtt
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

8.  Alternative splicing in disease and therapy.

Authors:  Mariano A Garcia-Blanco; Andrew P Baraniak; Erika L Lasda
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

9.  The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability.

Authors:  Rob D Chapman; Benoit Palancade; Andreas Lang; Olivier Bensaude; Dirk Eick
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

10.  High-affinity hnRNP A1 binding sites and duplex-forming inverted repeats have similar effects on 5' splice site selection in support of a common looping out and repression mechanism.

Authors:  Faiz-Ul Hassan Nasim; Stephen Hutchison; Mélanie Cordeau; Benoit Chabot
Journal:  RNA       Date:  2002-08       Impact factor: 4.942

View more
  25 in total

Review 1.  MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.

Authors:  Jonàs Juan-Mateu; Olatz Villate; Décio L Eizirik
Journal:  Eur J Endocrinol       Date:  2015-12-01       Impact factor: 6.664

Review 2.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

Review 3.  Alternative splicing: a pivotal step between eukaryotic transcription and translation.

Authors:  Alberto R Kornblihtt; Ignacio E Schor; Mariano Alló; Gwendal Dujardin; Ezequiel Petrillo; Manuel J Muñoz
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-06       Impact factor: 94.444

Review 4.  Coupling pre-mRNA processing to transcription on the RNA factory assembly line.

Authors:  Kuo-Ming Lee; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2013-02-07       Impact factor: 4.652

5.  Transcriptional Elongation Regulator 1 Affects Transcription and Splicing of Genes Associated with Cellular Morphology and Cytoskeleton Dynamics and Is Required for Neurite Outgrowth in Neuroblastoma Cells and Primary Neuronal Cultures.

Authors:  Juan Pablo Muñoz-Cobo; Noemí Sánchez-Hernández; Sara Gutiérrez; Younes El Yousfi; Marta Montes; Carme Gallego; Cristina Hernández-Munain; Carlos Suñé
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

6.  The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles.

Authors:  Noemí Sánchez-Hernández; Lidia Ruiz; Miguel Sánchez-Álvarez; Marta Montes; Maria J Macias; Cristina Hernández-Munain; Carlos Suñé
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 7.  Alternative RNA splicing and cancer.

Authors:  Sali Liu; Chonghui Cheng
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-06-13       Impact factor: 9.957

8.  SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.

Authors:  Heegyum Moon; Sunghee Cho; Tiing Jen Loh; Hyun Kyung Oh; Ha Na Jang; Jianhua Zhou; Young-Soo Kwon; D Joshua Liao; Youngsoo Jun; Soohyun Eom; Claudia Ghigna; Giuseppe Biamonti; Michael R Green; Xuexiu Zheng; Haihong Shen
Journal:  Biochim Biophys Acta       Date:  2014-09-08

Review 9.  Intellectual disability: dendritic anomalies and emerging genetic perspectives.

Authors:  Tam T Quach; Harrison J Stratton; Rajesh Khanna; Pappachan E Kolattukudy; Jérome Honnorat; Kathrin Meyer; Anne-Marie Duchemin
Journal:  Acta Neuropathol       Date:  2020-11-23       Impact factor: 17.088

Review 10.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.